J Korean Med Sci.  2024 Jul;39(27):e212. 10.3346/jkms.2024.39.e212.

What to Know Before Prescribing Antidepressants to Depressed Youths: A Focus on the Black Box Warning

• Hong M

• KMID: 2557782
• DOI: http://doi.org/10.3346/jkms.2024.39.e212

Reference

1. Organisation for Economic Cooperation and Development. Death by suicide, 2000 and 2020 (or nearest year). Accessed February 25, 2024. DOI: 10.1787/8389897a-en.

2. Statistics Korea. Accessed February 25, 2024. https://kostat.go.kr/synap/skin/doc.html?fn=118afe9c49b2407995dd4dc4dd08c563a0a3f9ad2e0218c5d74f954cb9174c3e&rs=/synap/preview/board/218/ .

3. Hopkins K, Crosland P, Elliott N, Bewley S. Clinical Guidelines Update Committee B. Diagnosis and management of depression in children and young people: summary of updated NICE guidance. BMJ. 2015; 350:h824. PMID: 25739880.

4. Martin A, Bloch MH, Volkmar FR. Lewis’s Child and Adolescent Psychiatry: A Comprehensive Textbook. 5th ed. Lippincott Williams & Wilkins;2017.

5. Teicher MH, Glod C, Cole JO. Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry. 1990; 147(2):207–210. PMID: 2301661.

6. Beasley CM Jr, Dornseif BE, Bosomworth JC, Sayler ME, Rampey AH Jr, Heiligenstein JH, et al. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. BMJ. 1991; 303(6804):685–692. PMID: 1833012.

7. Newman TB. A black-box warning for antidepressants in children? N Engl J Med. 2004; 351(16):1595–1598. PMID: 15483275.

8. Brent DA. Antidepressants and pediatric depression--the risk of doing nothing. N Engl J Med. 2004; 351(16):1598–1601. PMID: 15483276.

9. Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Erkens JA, et al. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry. 2007; 164(9):1356–1363. PMID: 17728420.

10. Sparks JA, Duncan BL. Outside the black box: re-assessing pediatric antidepressant prescription. J Can Acad Child Adolesc Psychiatry. 2013; 22(3):240–246. PMID: 23970915.

11. Bachmann CJ, Aagaard L, Burcu M, Glaeske G, Kalverdijk LJ, Petersen I, et al. Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005-2012. Eur Neuropsychopharmacol. 2016; 26(3):411–419. PMID: 26970020.

12. Kosky N, Baldwin DS. Off-label prescribing in psychiatric practice. Advances in Psychiatric Treatment. 2007; 13:414–422.

13. Braüner JV, Johansen LM, Roesbjerg T, Pagsberg AK. Off-label prescription of psychopharmacological drugs in child and adolescent psychiatry. J Clin Psychopharmacol. 2016; 36(5):500–507. PMID: 27529772.

14. Chon MW, Lee J, Chung S, Kim Y, Kim HW. Prescription pattern of antidepressants for children and adolescents in Korea based on nationwide data. J Korean Med Sci. 2017; 32(10):1694–1701. PMID: 28875616.

15. Kaminski JA, Bschor T. Antidepressants and suicidality: A re-analysis of the re-analysis. J Affect Disord. 2020; 266:95–99. PMID: 32056952.

16. Spielmans GI, Spence-Sing T, Parry P. Duty to warn: antidepressant black box suicidality warning is empirically justified. Front Psychiatry. 2020; 11:18. PMID: 32116839.

17. Yang CM, Shim SH, Bahk WM, Woo YS, Jeong JH, Wang SM, et al. Korean Medication Algorithm Project for Depressive Disorder 2021 (III): Child and Adolescent. J Korean Neuropsychiatr Assoc. 2021; 60(3):193–203.